Rethinking Prevention of Recurrent Bacterial Vaginosis: A Comparative Effectiveness Network Meta-Analysis.
Barbara Gardella, Mattia Dominoni, Martina Rita Pano et al.
✦ AI-curated · Sources linked
In 30 seconds
This network meta-analysis evaluated the effectiveness of various preventive strategies for recurrent bacterial vaginosis (BV) in nonpregnant women. It found that partner treatment significantly reduced BV recurrence rates (IRR=0.76, 95% CI=0.60-0.98) compared to placebo. Other effective interventions included vaginal probiotics and acidifying agents, particularly in women with varying baseline recurrence risks.
Key findings
- Partner treatment reduced BV recurrence rates (IRR=0.76, 95% CI=0.60-0.98) compared to placebo.
- Acidifying agents significantly reduced early recurrence (RR=0.22, 95% CI=0.08-0.62) in consolidation therapy.
- Vaginal probiotics were effective in long-term prevention (IRR=0.74, 95% CI=0.58-0.96).
- Intermittent antibiotic suppression showed a significant reduction in recurrence among high-risk women (IRR=0.39, 95% CI=0.21-0.73).
Why it matters
Understanding effective prevention strategies for recurrent bacterial vaginosis is crucial for improving patient outcomes. This analysis highlights nonantibiotic options that can be integrated into clinical practice, potentially reducing reliance on antibiotics and associated side effects.